Understanding Daily Changes in BDD Risk Using Smartphones
NCT ID: NCT04254575
Last Updated: 2023-09-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
87 participants
OBSERVATIONAL
2020-07-15
2023-04-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Using Mobile Technology to Better Understand and Measure Self-Regulation
NCT03352713
Decision Making, Daily Experiences, and Brain Activity in Young Adult Women
NCT04125589
Smartphone-based Aftercare for Inpatients With Bulimia Nervosa
NCT05728021
The Use of Smart Devices in Capturing Digital Biomarkers in Eating Disorders
NCT06544226
Optimizing a Smartphone Application for Individuals With Eating Disorders
NCT02503098
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
body dysmorphic disorder (BDD)
Adults with a current primary diagnosis of body dysmorphic disorder (BDD)
None, observational study only (no interventions)
None, observational study only (no interventions)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
None, observational study only (no interventions)
None, observational study only (no interventions)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Current primary diagnosis of BDD
* BDD severity \>= moderate
* Living in US
* English proficiency
* Owns an Android or iOS (Apple) smartphone
* Has regular Wifi-enabled internet access for data downloads
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Massachusetts General Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hilary Weingarden
Psychologist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hilary Weingarden, PhD
Role: PRINCIPAL_INVESTIGATOR
Massachusetts General Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Massachusetts General Hospital
Boston, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Weingarden H, Jaroszewski AC, Armey M, Hoeppner BB, Armstrong CH, Onnela JP, Wilhelm S. Predicting concurrent and short-term desire and intent to attempt suicide among people with body dysmorphic disorder using ecological momentary assessment of anxiety and shame. J Psychopathol Clin Sci. 2025 Oct 6. doi: 10.1037/abn0001054. Online ahead of print.
Weingarden H, Meng X, Armey M, Onnela JP, Jaroszewski A, Armstrong CH, Wilhelm S. Predicting the strength of next-day negative emotion states in body dysmorphic disorder using passive smartphone data: An intensive longitudinal assessment study. Internet Interv. 2025 May 15;40:100833. doi: 10.1016/j.invent.2025.100833. eCollection 2025 Jun.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2019P002041
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.